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ABSTRACT
The independent versus joint effects of insulin and
thyroid hormone (T3) on soleus muscle glucose transport
protein (GLUT4) trafficking were assessed in diet-induced
obese (DIO) insulin resistant rats, a model for type 2
diabetes mellitus. Wistar and Sprague-Dawley (SD) rats were
compared after high-fat (HF) feeding during which Wistar
rats gained weight faster and achieved higher final body
weights than SD rats. Oral glucose tolerance tests revealed
insulin resistance in the Wistar rats and these animals
were subsequently given streptozotocin to block insulin
production followed by insulin injections at doses of 1
IU/kg BW to induce normoglycemia or a half dose of 0.5
IU/kg to mimic fasting serum insulin levels. Animals were
fed or fasted overnight to manipulate serum T3
concentrations. Fasting lowered serum T3 in animals
receiving full insulin replacement but not in low insulin
dose animals. GLUT4 concentrations were unchanged by
treatments which confirmed insulin resistance. However,
serum glucose concentrations were still reduced by the high
insulin dose indicating a persistent peripheral insulin
response. This study revealed a role for insulin in the
t
regulation of serum T3 that offers a novel pathway for
iii
integrating the daily insulin concentrations for the long­
term regulation of skeletal muscle GLUT4 expression by T3.
iv
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CHAPTER ONE
INTRODUCTION
Obesity and Type 2 Diabetes in the 21st Century 
As this country enters the new millennium, it faces a
precipitous rise in the rate obesity and its co-morbid
conditions. Over the past two decades, the prevalence of
obesity in the United States has risen by about 50% and
shows no signs of abating (Rippe et al, 2001). The
prevalence and severity of obesity affects both men and
women and virtually all ethnic groups. Childhood and
adolescent obesity also continues to rise rapidly (Troiano,
et al, 1995; NIH, 1996). In a recent study by the
University of Southern California, it was estimated that
the annual cost of 16-17 year-olds in hospitals due to
obesity has reached $127 million per year (Goran & Cruz,
2003). An estimated 300,000 deaths annually are
attributable to obesity in the United States, thus ranking
obesity-related factors second only to smoking among the
leading causes of preventable death in adult Americans
(Rippe et al, 2001).
While it has been hotly debated whether this rising
problem with obesity is due to genetic or environmental
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factors, the scientific community has reached a consensus
that while genes make certain individuals more susceptible
than others, behavior has played a crucial role in the
population's attitude toward nutrition, exercise and
fitness, exacerbating this epidemic. The occurrence of
obesity is, therefore, influenced by a complex interaction
of genetic, environmental and behavioral factors (Rippe et
al, 2001; Pi-Xunyer, 2002). The major difference in
lifestyle between now and forty years ago is the
disproportionately high intake of calorie-rich foods in the
absence of the required energy expenditure to burn the
excess fuel. These factors are compounded in individuals
who display the propensity for weight gain even though they
eat as much as another, less susceptible individual
(McGarry, 2001). The earlier stages of this type of
metabolic dysregulation is called Metabolic Syndrome X,
which occurs when an individual displays hyperinsulinemia
with concomitant hyperglycemia due to insulin resistance of
peripheral tissues like the liver and the skeletal muscle.
Type 2 diabetes mellitus occurs when pancreatic beta cell
failure takes place and the individual no longer
synthesizes or secretes endogenous insulin (McGarry, 2001).
Type 2 diabetes has long been labeled as a disease of
2
inadequate glycemic control that is accompanied by obesity.
However, it has recently come to light that defects in
fatty acid metabolism may be the actual cause of the
insulin resistance characteristic of type 2 diabetes,
strengthening the connection between obesity and insulin
resistance (McGarry, 2001; Kuhlmann et al, 2003).
Lipids and Insulin Resistance
Dennis McGarry introduced a novel idea that lipid
accumulation inside the skeletal muscle, or
intramyocellular lipids (IMCL), plays a major role in the
onset of insulin resistance and hyperglycemia (McGarry,
2003). While the exact mechanisms have yet to be
elucidated, this hypothesis suggests a role for fatty acids
in the derangement of the regulatory pathways that control
everything from insulin transduction to transcription
factors in the skeletal muscle, adipocytes, vascular
endothelium and the liver (D'Alessandro et al, 2000).
Because it is a critical site of glucose disposal, and
because it constitutes the greatest tissue mass, skeletal
muscle is considered the main contributor to hyperglycemia
due to defective insulin-controlled glucose regulation
(Peterson & Shulman, 2002). Individuals who are
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predisposed to obesity have been found to have a decreased
capacity to oxidize fatty acids in their skeletal muscle
which leads to the accumulation of IMCL and the subsequent
inability of the muscle to respond to insulin signaling
(Kim et al, 1999; Tremblay et al, 2001). Excess IMCL
accumulation prevents the muscle from taking up and
utilizing glucose through the normal pathways, thus leading
to its accumulation in the blood and subsequent
hyperglycemia (Laybutt et al, 1999) . Insulin resistance in
the muscle, therefore, is the root of defective glucose
homeostasis. Skeletal muscle insulin resistance becomes
further exacerbated by hepatic insulin resistance, which
causes excessive glucose release into the bloodstream
(Peterson & Shulman, 2002; Standaert et al, 2002). -
Glucose Homeostasis
Since the recent focus of diabetes research has been
on fat metabolism and how it affects a tissue's ability to
regulate glucose, it is important to study the mechanism by
which glucose regulation takes place. One such mechanism
addresses the means by which the hydrophilic glucose
molecule is able to cross cellular membranes. The chemical
nature of this molecule requires that it be transported
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though the hydrophobic domain of membranes in order to pass
first into the cytoplasm by crossing the plasma membrane,
and then to different subcellular compartments by crossing
organellar membranes.
There are seven identified glucose transporter
proteins, GLUT1 through GLUT7. Different tissues have
characteristic expression patterns of glucose transporter
proteins that serve as controlled gates to take glucose in
and out of the cell depending on serum glucose
concentrations. The skeletal muscle has GLUT4 proteins
that respond to insulin by increasing their numbers in the
plasma membrane (Figure 1). High serum glucose initiates
insulin secretion, which increases serum insulin
concentrations that act on the skeletal muscle insulin
receptors in order to stimulate GLUT4 translocation from
the cytoplasm to the cell membrane to take glucose out of
the blood, and promoting storage as glycogen, thereby
lowering serum glucose levels (Watson & Pessin, 2001).
When insulin resistance occurs, as in DM2, the insulin
signaling cascade fails to properly initiate normal
cellular responses due to the presence of excess lipids in
the skeletal muscle. Under these circumstances GLUT4
proteins fail to translocate, dock and fuse into the plasma
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membrane thus preventing glucose uptake from the blood (Kim
et al, 2000; Dietz et al, 2002). This contributes to the
excess glucose accumulation in the serum and partially
explains the basis for hyperglycemia associated with type 2
diabetes mellitus.
In vivo NMR studies have shown glucose transport
across the plasma membrane by GLUT4 to be a key regulatory
point in insulin-mediated muscle glycogen synthesis, a key
step in glucose uptake that limits glycogen synthesis
(Rothman, 2001). Because increases in plasma free fatty
acid concentrations can reduce GLUT4 trafficking to the
plasma membrane, thereby inhibiting glucose transport, this 
suggests that defects in fatty acid metabolism do indeed 
have a key role in the pathogenesis of DM2 by interfering
with insulin activation of glucose transport into the
myocyte (Peterson & Shulman, 2002).
Fasting and Nonfasting In Vivo Metabolism
While McGarry's theory has been well-researched and
has gained support from the diabetes research community
(Peterson & Shulman, 2002), most of the studies concerning
fatty acid metabolism and glucose regulation have been done
using animals in the fasted state (McGarry, 2001). Because
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fasting has profound and persistent effects on metabolism
and the hormones that regulate substrate-utilization, it is
difficult to envision how results obtained from fasted
animals reflect the natural metabolic state of animals that
are obese due to chronic over-eating (Cettour-Rose et al,
2002). In our own lab, skeletal muscle from high-fat (HF)
fed rats was found to be able to oxidize IMCL while
maintaining serum glycemia at the level of the lean
control-fed animals (Jun & Fehn, 2003). Two key
differences in our study and those of other investigators
were the use of non-fasted animals and the concurrent
analysis of both the extramyocellular lipids (EMCL)
surrounding the myocyte and the IMCL deposits. IMCL in
comparison to the EMCL revealed lipid influx into the IMCL
lipid stores. However, the results from similar studies
should be interpreted with caution and their methodology
closely examined because many of these studies have
measured total muscle lipids from whole muscle homogenates
rather than distinguishing EMCL and IMCL by morphological
analysis as was done in our lab. In light of this
unexpected finding that the EMCL decreased in direct
proportion to rising IMCL levels, we concluded that it is
more likely that the skeletal muscle may, in fact,
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preferentially utilize lipids, rather than being unable to
use glucose as a substrate. This finding was also
confirmed through indirect calorimetry which showed that
the animals were utilizing lipids as their metabolic
substrate (Jun & Fehn, 2003; Kelley & Mandarino, 2000).
The shift to lipid oxidation is proposed to reduce glucose
utilization, thereby contributing to the elevation of serum
glucose concentrations that result from decreased disposal.
In a subsequent study we discovered that plasma membrane
GLUT4 concentrations in the skeletal muscle of the non-
fasted obese animals were proportionate to the plasma
insulin levels (Jun & Fehn, 2003) indicating the
persistence of insulin responsiveness. Our results stand
in sharp contrast to the dominant paradigm that insulin
resistance due to IMCL is the main pathology underlying
type 2 diabetes(McGarry, 2001; Jun et al, 2004). The one
variable that has remained different in our studies in
comparison to others is the use of non-fasted subjects.
Nutrient Regulation by Leptin and Thyroid Hormone
A complete picture of the physiology that underlies
type 2 diabetes involves essentially every system in the
body. The main theme throughout the study of this disease
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is the dysfunctional trafficking of nutrients between
various synthetic and storage compartments such as the
liver, adipose tissues, and the skeletal muscle (Figure 2)
(Lewis et al, 2002; Fehn et al, 2002). These compartments
are intricately regulated principally by the peripheral
sympathetic nervous system pathways that are under central
nervous system control at the hypothalamus (Flier et al,
2000). The main control center for appetite and satiety,
the hypothalamus, is a key regulator of feeding and
metabolism. It gains information about peripheral food
stores via nutrient-sensing pathways that involve hormonal
signaling through the leptin and thyroid hormone pathways
(Figure 3) (Fehn et al, 2002; Flier et al, 2000).
Leptin is a hormone secreted in proportion to the
amount of fat stored in adipocytes and it regulates feeding
by acting as a nutrient level indicator for the brain.
While leptin has been thought of mainly as a satiety factor
or the stop signal for feeding, it is more likely a "fuel
gauge," signaling the hypothalamus of lowered nutritional
status. Leptin increases metabolism by stimulating
hypothalamic activity that is carried out through the
peripheral sympathetic neurons, particularly in the
skeletal muscle (McGarry, 2001; Flier et al, 2000) . Leptin
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works closely with the thyroid hormone 3,5,3'
triiodothyronine (T3) in order to control the desire to eat
and to signal satiety stop when the individual has
consumed sufficient quantities of food (Castello et al,
1994; Diano et al, 1998). Because the hypothalamic
responses to leptin are conveyed to peripheral tissues
through sympathetic neurons, T3 can increase peripheral
responsiveness to leptin-regulated processes by enhancing
expression of (3-adrenergic receptors in target tissues like
the liver, adipose tissues and the skeletal muscle (Chu et
al, 1985; McGarry, 2001; Peterson & Shulman, 2002). Thus,
there is a clear link between the regulation of metabolic
responses by leptin and their modulation by thyroid hormone
(Fehn et al, 2001; Fehn et al, 2002). In as much as the
serum concentration of thyroid hormone is altered by
fasting, this is but one source of potential error in
interpreting studies of metabolic regulation by leptin
using subjects with restricted food intake.
At the level of target tissues, T3 controls additional
response elements which must be taken into consideration
when evaluating metabolic regulation. In addition to being
responsive to insulin, skeletal muscle GLUT4 protein
synthesis as well as trafficking are also stimulated by T3.
10
Thyroid hormone action on gene expression is mediated
primarily at the level of gene transcription and is most
prominent in the red muscle fiber types although thyroid
hormone stimulates GLUT4 expression in both red and white
skeletal muscle fiber types (Castello et al, 1994).
Studies by Torrance et al (1997) have demonstrated that
administration of T.3 was highly effective in augmenting
GLUT4 mRNA and protein expression in obese-insulin
resistance rat skeletal muscle of animals that were induced
into hypothyroidism prior to treatments. This work points
out the potential for thyroid hormone mediated GLUT4
expression in insulin resistance when T3 is replaced to
correct a pathological hypothyroid state, but it failed to
test whether these actions are in effect under the
thyroidal status normally present in obese diabetic
subj ects.
The thyroid system is regulated at multiple levels,
one or more of which might account for nutritional
adaptation. First, thyrotropin-releasing hormone (TRH), a
neuropeptide produced in the paraventricular nucleus (PVN)
of the hypothalamus, controls the release of thyroid-
stimulating hormone (TSH) from the pituitary. TSH acts on
receptors on the thyroid to promote synthesis and release
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of the inactive thyroid hormone T4 which is then converted
to T3 in peripheral tissues like the liver and kidney
(Figure 3) (Flier et al, 2000; Silva et al, 1982). T3 is
released post-prandially in order to increase metabolism
and promote lipolysis (Wilcox et al, 1991; Hoppner & Seitz,
1989) and probably hepatic lipogenesis. In a lean
individual, T3 elicits skeletal muscle thermogenic activity
through the induction of uncoupling proteins (UCPs) for
non-shivering thermogenesis and stimulates GLUT4
trafficking to the skeletal muscle plasma membrane (Ribiero
et al, 2001; Castello et al, 1994; Torrance et al, 1997).
Our lab has established that T3 reduces IMCL stores while
raising fatty acid metabolism in the skeletal muscle (Fehn
et al, 2002; Goodridge et al, 2003). This again
contradicts findings in the majority of the current
literature on diabetes research, in which defective
skeletal muscle lipid oxidation is often cited as the root
of insulin resistance (McGarry, 2001; Tremblay et al,
1995). The practice of fasting, therefore, becomes even
more critical since the dramatic and persistent decline in
circulating T3 levels prior to treatment can affect
parameters such as whole-body metabolism, especially
glucose homeostasis and substrate utilization. The goal of
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this thesis was to address the potentially large role that
fasting could have in the obese, diabetic animal model and
their insulin sensitivity.
Current models of obesity and the development of type
2 DM have proposed that if an individual overeats, that
he/she can eventually become insensitive to the satiety
signals that control appetite, thereby becoming obese and
perpetuating the oversecretion of hormones like insulin.
Such a dysregulation of nutrient intake can lead to excess
lipid accumulation in peripheral tissues that eventually
causes secondary defects in metabolism such as insulin
resistance (McGarry, 2001; Tremblay et al, 2001; Hawkins et
al, 2002) . Similarly, chronic over-nutrition could promote
excessive thyroxine deiodination leading to chronic
elevations in serum T3. Alternatively, peripheral
resistance to T3 may arise just as it has been theorized
that insulin resistance arises when tissues like the liver
and skeletal muscle fail to respond to elevated serum
insulin in the presence of excess fats (Boden et al, 2001,
McGarry, 2001). Physiological systems often see the loss
of regulation as a loss of the signal altogether. Such a
sequence of events would lead to the accumulation of IMCL
and the development of insulin resistance that could
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progress and develop into overt type 2 diabetes
(Chatterjee, 2001). These are potential sequela that
warrant further attention if the normal progression toward
type 2 diabetes is to be understood.
It is well-established that the serum concentrations
of both insulin and thyroid hormone drop dramatically after
an overnight fast in non-obese animals, but these responses
have not been investigated simultaneously in the diet-
induced obese-diabetic rat model (Byerley & Heber, 1996;
Diano et al, 1998). An overnight fast is a practice that
is standard in clinical and animal research studies. This
method is known to cause a sharp drop in the level of T3,
mainly due to the lack of conversion from T4 to T3 by Type I
deiodinase (Byerley, 1996; Fehn et al, 2001). Since T3 is
an established stimulant of GLUT4 expression in the
skeletal muscle, the interpretation of results from
experiments that use fasted animals as their subjects may
be compromised (Torrance et al, 1997). The proposed work
sought to bridge this gap by characterizing the effects of
fasting on serum concentrations of insulin and T3 and GLUT4
trafficking in the skeletal muscle of high-fat diet induced
insulin resistant diabetic rats.
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Purpose of the Thesis
This thesis project will investigate the effects of
fasting on the serum levels of two key regulatory hormones,
insulin and thyroid hormone (T3) and the effects of these
hormones on the trafficking of GLUT4 in soleus muscle.
From this it will be possible to characterize the ability
of T3 to independently stimulate GLUT4 trafficking in the
diet-induced obese-diabetic rat model.
Pilot Study on Hormone Interactions
In considering potential experimental designs, a pilot
project was done to determine whether T3 alters plasma
insulin concentration in the fasted state. T3
administration during fasting restored plasma insulin
concentrations back to the levels of the non-fasted group.
In the group that was fasted and then given replacement T3,
their serum insulin and T3 values were (mean+SEM) 93.2 +
26.1 plU/ml and 81.8 + 15.8 ng/dl, respectively. The
control animals were fed ad libitum. Their serum insulin
and T3 values were 83.8 + 9.5 plU/ml and 86.4 + 17.3 ng/dl,
respectively. Fasting with T3 replacement, therefore, could
not be used as an experimental manipulation to study
thyroid hormone-regulated skeletal muscle GLUT4 trafficking
15
in the presence of fasting concentrations of insulin
(Appendix B).
Independent versus Joint Effects of Insulin and T3
This study aims to evaluate the independent versus
joint effects of insulin and T3 on GLUT4 trafficking using a
novel approach to in vivo metabolic manipulation. Wistar
rats will be fed a high fat diet for 11 weeks to create
insulin-resistant, diet-induced obese (DIO) animal models.
After insulin resistance is confirmed, all animals will be
given streptozotocin (STZ) to stop endogenous insulin
secretion by the pancreatic beta cells, thereby allowing
the administration of replacement doses of insulin to mimic
serum insulin levels in animals that are either fasted
overnight or fed ad libitum to modify endogenous T3
concentrations. Exogenous insulin administration will be
paired with normal serum T3 concentrations in animals
permitted to feed ad libitum and with animals deprived of
food overnight to induce fasting concentrations of T3. This
will provide four combinations of fed and fasting
concentrations of insulin and T3 from which to evaluate the
interaction of these hormones on soleus muscle GLUT4
16
transporter trafficking in a model of diet-induced insulin
resistance.
17
CHAPTER TWO
MATERIALS AND METHODS
Animals
Study 1
Male Sprague-Dawley rats (Harlan Labs) weighing 51-75
grams were housed in groups of 3-4 per cage and maintained
at 21-25°C, 14:10 hours light:dark (light 0600-2000h). All
animals were fed a high-fat rodent chow with 45% of the
total kilocalories derived from fat (Research Diets, Inc.).
Food was available ad libitum throughout the study.
Study 2
Male Wistar rats (Charles River) weighing 50-75 grams
were housed in groups of 3-4 per cage and maintained at 21-
25°C, 14:10 hours light:dark (light 0600-2000h). All
animals were fed a high-fat rodent chow with 45% of the
total kilocalories derived from fat (Research Diets, Inc.)
until they reached 17-19 weeks of age Food was available
ad libitum until the experimental treatments began, when
the animals were either fasted or non-fasted, as described
below.
Prior to group assignment, each animal underwent an
oral glucose tolerance test (OGTT) in order to confirm
18
impaired insulin sensitivity compared to non-diabetic
animals. Animals were fasted for 16 hours and then given a
40% glucose solution (Sigma Biochemical Co.) via an oral
gavage tube at a dose of lg glucose/kg body weight. Blood
samples were collected by heel-stick using Safe-T Pro
Lancets (Roche Pharmaceuticals). Blood glucose values were
measured using Comfort Curve test strips in an Accu-Chek
glucose meter (Roche Pharmaceuticals) at 0, 30, 60, 90, and
120 minutes following the oral glucose load.
Experimental Treatments
Study 1. Diet-induced Obesity (DIO)
and Insulin Resistance in Response
to High Fat Feeding
Groups of 43 male SD and 32 male Wistar rats that were
provided high fat diet (as described above) were subjected
to OGTT to confirm insulin resistance. SD animals served
as high fat fed DIO animals refractory to induction of
insulin resistance and Wistar animals served as the DIO
responsive model. The insulin resistant Wistar animals
were then employed for subsequent studies, as described
below.
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Study 2. Interactive Effects of Insulin
and T3 on Soleus Muscle GLUT4 Trafficking -
Ablation of Pancreatic Beta Cells
and Insulin Secretion by
Streptozotocin (STZ)
Wistar rats having confirmed insulin resistance were
divided into respective treatment groups (Table 1). In
order to eliminate endogenous insulin production, all
animals were fasted overnight and then received 80 mg/kg
body weight streptozotocin (STZ, Sigma Biochemical Co.).
The solution was prepared immediately before injection (20
mg/ml STZ in 0.05 M citrate, 0.15 M NaCl, pH 4.5,).
Injections were administered intraperitoneally (i.p.)
between 0800-0900h to induce type 1 diabetes as previously
described (Zhou, 2004). Starting on the day after STZ
injections, animals were provided with a 10% glucose
solution to prevent hypoglycemia resulting from attenuated
pancreatic alpha cell glucagon secretion that results from
insulin deficit (Zhou, 2004). Type 1 diabetes was
confirmed on the second day after the STZ injections using
blood from heel-sticks and the Accu-chek method, as
described above. All animals were given 1 unit (U) of
Humulin N insulin (Lilly Pharmaceuticals) subcutaneously
into their lower backs in order to prevent diabetic
20
complications and loss of life due to hypoinsulinemia and
severe hyperglycemia.
Groups 1 and 2 served as the DIO fasted groups in
which serum T3 was reduced to the normal fasting
concentration which would be complemented by either a full
replacement dose of insulin (2 U) or a partial insulin dose
(1 U) of Humulin N (Lilly Pharmaceuticals). Groups 3 and 4
were provided food (not fasted) in order to maintain normal
non-fasting serum T3 concentrations while being provided
either the full or partial replacement dose of Humulin N.
Tissue Collection
Animals were euthanized in a CO2 chamber which rendered
them anesthetized, unconscious, and led to ventilatory
arrest prior to death. Upon cessation of ventilation but
prior to cardiac arrest approximately 1.0 ml of blood was
withdrawn via cardiac puncture using a 23 gauge needle and
a 1 ml syringe (BD Medical Supplies). The blood was placed
on ice for approximately 15 minutes to allow clotting and
then centrifuged at l,000g for 10 minutes in order to
separate the serum from the whole blood cells. Serum
samples were aliquoted into separate 1.5 ml eppendorf tubes
and stored in liquid nitrogen prior to RIA. Subsequent
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bilateral thoracotomy and cardiac excision ensured that the
procedure was terminal. The entire soleus muscle from each
leg was collected from each animal and frozen in liquid
nitrogen for storage prior to assay.
In Vivo Metabolic Analyses
Prior to and during the treatments, in vivo metabolic
rates of each animal were measured through indirect
calorimetry 10 minute•readings at 400 ml/min using a flow­
through system (Ametek Model S-3A Oxygen Analyzer and Model
CD-SA Carbon Dioxide Analyzer) in order to quantify the
amount of oxygen consumed and the carbon dioxide released
in respiratory gasses. These measurements were used to
compute the respiratory quotient (RQ = ml CO2 released/ml O2
consumed) that reflects the type of fuel (i.e. fats,
carbohydrates or proteins) that the animals were utilizing
as their primary energy source (Table 2). Baseline RQ
readings were measured prior to treatments and throughout
the 11-13 weeks of high-fat feeding.
Serum Hormone and Glucose Assays
Terminal point data include serum thyroid hormone
concentrations (T3) , serum concentrations of insulin, blood
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glucose levels and GLUT4 protein concentrations in the
soleus muscle. Serum concentrations of insulin and thyroid
hormone (T3) were determined by commercial radioimmunoassay
(RIA) (MP Biomedicals). Serum glucose concentrations were
determined by the glucose oxidase colorimetric method
microassay (Sigma Biochemical Co.) in a 96-well microtiter
plate read at 520 nm.
Soleus Muscle GLUT4 Quantification
Immediately following removal from liquid nitrogen,
0.10 g of soleus muscle was placed in 1 ml of ice-cold STM
buffer (lOmM NaCl, 50mM Tris HC1 pH 8.0, and lOmM MgCl2 in
distilled water). The mixture was homogenized on ice at
maximum speed (Con-Torque) for one minute using a ground
glass pestle. The homogenates were centrifuged at 4 °C at
14,000g for five minutes to separate cytoplasmic vesicles
containing GLUT4 from the plasma membrane GLUT4 fraction.
The supernatant (cytoplasmic vesicular GLUT4 fraction) was
aliquoted into a fresh tube. The pellet (plasma membrane
GLUT4 fraction) was resuspended in 1 ml of ice-cold STM and
sonicated (Fisher Scientific Model 500 Sonic Dismembrator
with Ultrasonic Converter Model CL4) at setting "5" for 30
seconds to remove the docked vesicles and fused GLUT4
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proteins from the plasma membranes. The sonicated fraction
was centrifuged at 14,000g for 5 minutes at 4°C to separate
the GLUT4 from the vesicles and the membrane. The
supernatant (now containing only the plasma membrane GLUT4
protein fraction) was aliquoted into a fresh 1.5 ml
microcentrifuge tube and the pellet discarded. The protein
concentration in each homogenate was determined using the
Bradford Assay (BioRad). Samples for subsequent analysis
were standardized to each contain 100 pg of total protein
and brought to 1000 pi with STM. Bovine serum albumin
(Fraction V, Pierce) was used to generate the standard
curve.
To each sample containing lOOpg of total protein, 5 pi of
diluted anti-GLUT4 primary antibody (5 pi primary antibody
in 45 pi STM) GLUT4 antibody (GLUT4 rabbit polyclonal IgG,
Santa Cruz Biotech) were added and each sample was
vortexed. The samples were incubated at 4 °C overnight to
allow binding of primary antibody to GLUT4 proteins. Then
20 pi Protein A-Agarose (Santa Cruz Biochemicals) were
added to each sample and each sample was vortexed. The
samples were incubated at 4 °C overnight while rocking to
allow binding of the Protein-A Agarose to the primary
antibody. Samples were then centrifuged at 14,000 g for 5
24
minutes at 4 °C. The supernatant was removed and the pellet
rinsed in 1 ml of ice-cold 1 x PBS (0.137 M NaCl, 0.00268 M
KC1, 0.00147 M KH2PO4, 0.00801 M Na2HPO4 -7H20, pH 7.3,
autoclaved). Samples were rinsed, vortexed and centrifuged
a total of three times in PBS. After the final rinse, 50
pi of lx Laemmli treatment buffer (0.0625M Tris HC1 pH 6.8,
2% SDS, 10% Glycerol, 5% 2 ((3) -mercaptoethanol) was added to
the isolated GLUT4 pellet. The samples were stored at 4 °C
prior to gel electrophoresis.
The proteins were denatured by boiling for five minutes
in a water bath and 15 pi of each sample was loaded onto a
0.75mm thick, 12% single concentration Tris-Glycine gel for
electrophoresis (Jules, Inc.). Additionally, 5 pi of
Molecular Weight Marker (Santa Cruz Biochemicals) were
loaded onto each gel containing the samples. The gels were
run for 40 minutes at 35 mA per gel (Hoefer 'Scientific
instruments Mighty Small SE260; EC Apparatus Corp. EC-400
Power Source) in Laemmli tank buffer (0.025 M Tris, pH 8.3,
0.192 M Glycine, 0.1% SDS) with a refrigerated water
circulator to maintain the temperature at 4 °C (Cole Palmer
Model 1268-14).
The proteins were transferred (Hoefer Scientific
Instruments Model TE42) onto nitrocellulose (NC) membrane
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(Osmonics) at five amperes overnight in Towbin buffer (0.25
M Tris, 0.192 M Glycine, 20% methanol, pH 8.3). Success of
the transfer was confirmed by staining the gels with
Coomassie Brilliant Blue to ensure absence of any remaining
protein on the gel. The NC was blocked for 60 minutes in
Blotto (5% Carnation Dry Milk in Tris Buffered Saline -
20mM Tris, 500 mM NaCl, pH 7.5), and the second incubation
was carried out overnight at room temperature with shaking
in 20pl primary antibody (Santa Cruz Biotech, GLUT4 rabbit
polyclonal IgG) diluted in 100 ml blotto. This was
followed by three TBS rinses of five minutes each. Then
the NC membrane was incubated overnight in 20pl secondary
antibody (Goat anti-rabbit IgG-HRP, Santa Cruz) diluted in
100ml Blotto followed by three ten minute rinses in
TBS/0.05% Tween. Lastly, the NC membrane was rinsed in TBS
once for five minutes. Equal volumes of Western Blotting
Luminol Reagents A and B (Santa Cruz Biochemical Co.) using 
0.125ml (125 pi) per cm2 of NC was used to incubate the NC 
for one minute. The NC was exposed and the film (Fuji
Super RX, 8 x 10 in) developed' using a Mohr Enterprise
Model VP-200-ST film developer. GLUT4 concentrations were
determined using NIH Image J software to obtain
uncalibrated optical densities (OD) of the bands visualized
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using transmittance digital photograph images of the films
(UMAX Astra 1220U scanner).
Data Analyses
Statistical analyses were performed using SigmaStat
Software (Version 3.1). All data are expressed as
mean+SEM. Strain weight gain data was analyzed using one­
way ANOVA in order to compare between groups of animals of
varying ages. The effects of feeding status and insulin on
serum hormone and blood glucose levels, glucose tolerance,
and PM GLUT4 concentrations were analyzed using two-way
ANOVA. Tukey post-hoc analysis was used for multiple
comparisons in order to see which groups differed. ANOVA
tables of critical values are listed in Appendix C.
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CHAPTER THREE
RESULTS
High-Fat Diet and Weight Gain
Growth curves for male Wistar and Spraque-Dawley rats
fed high-fat chow are shown in' Figure 4. In the first 28
days, the Wistar animals gained, on average, 305 g and 
approximately 20-46 g/week thereafter, with maximal body
weights of 501.3+ 9.2 g being attained at 78-82 days of age
(DOA). In comparison, the Sprague-Dawley rats (SDs) that
began the same diet at the same age required 145-159 days
to attain similar maximal weights of just under 500 g. The
Wistar rats showed an increased propensity for early weight
gain by attaining higher body weights by 78-82 DOA in
comparison with SDs at 145-159 DOA (501.3+9.2 v. 482.9 +
7.44 g, respectively; P< 0.001; Table 3).
In Vivo Metabolic Analyses
In vivo indirect calorimetry was performed on the
Wistar animals prior to and on the day of the STZ
injections in order to assess which type of fuel the
animals were metabolizing (Figure 5). A progressive shift
toward higher RQ values as high-fat feeding continued
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indicates that the animals were increasing carbohydrate
utilization at the expense of lipid oxidation, as is
typical of obese individuals developing insulin resistance
(Bray & Bouchard, 2004). A drop in the RQ value on the
last set of readings corresponds to the day following an
overnight fast and injection of STZ in the previous
evening. It should be noted that the values are slightly
above 1.0 probably due to moisture in the analyzers that
skewed the gas concentrations slightly.
Oral Glucose Tolerance Tests
All Wistar animals were confirmed to be insulin-
resistant after an OGTT demonstrated impaired glucose
tolerance following a 16h fast (Figure 6). The blood
glucose concentrations were increased by 60% at 60 minutes
following an oral glucose gavage and they remained elevated
at 90 and 120 minutes, indicating a lack of glucose uptake
by normal target tissues. In comparison, the non-resistant
Sprague-Dawley rats showed blood glucose restored to
baseline within 90 minutes of administering the glucose
challenge. The blood glucose levels in the Wistar rats
were greater than those in the SD rats by approximately
11%, 14%, and 17% at 60, 90, and 120 minutes, respectively
29
(P<0.05; Table 4). The Sprague-Dawley strain, which was
found to be non-resistant, experienced a full recovery at a
faster rate than the Wistar strain. At 60 minutes after
the oral glucose load the serum glucose values of Wistar
rats were higher and this continued through 120 minutes
indicating insulin resistance. It is interesting to note
that the SD rats actually began the OGTTs with higher
baseline fasting blood glucose levels at 0 minutes.
. Serum T3, Insulin and Glucose Levels
In the presence of full doses of insulin (hi groups),
as would be present in fed animals, fasting caused a
significant decrease in serum T3 concentrations (Figure 7)
(p<0.01; Table 5). Interestingly, there was also a
significant (p<0.05) decrease in serum T3 in the fed (y)
animals, with lower levels seen in the animals given the
low (lo) dose of insulin, indicating possible interaction
of the two hormones (Table 3). However, this was not seen
in the fasted animals. All animals given the lower dose of
insulin exhibited significantly reduced serum T3 levels,
suggesting that insulin may play a role in stimulating
peripheral deiodination rates that are responsible for T3
production. Whether T3 and insulin act as antagonists to
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each other is also a possibility, since each hormone has
opposite effects on nutrient metabolism, with T3 promoting
breakdown and insulin promoting storage.
Exogenous insulin administration resulted in higher
serum insulin levels (Figure 8) (P<0.05; Table 6) in those
animals that received the full replacement dose of 2 IU and
lower serum levels in the animals that received the low
dose (1 IU). This verified that the treatments provided
the animals with the proper high and low serum insulin
concentrations that were specified in the treatment
protocol (Figure 8).
The impact of the insulin-T3 treatment combinations on
serum glucose concentration is shown in Figure 9. In the
presence of high serum insulin concentrations representing
a nonfasting state, a mild decrease in serum glucose was
observed. All animals exhibited hyperglycemia, as would be
expected in the insulin-resistant, DIO model. However, the
animals that received high insulin doses did exhibit some
lowering of blood glucose levels when compared to the
groups that received low insulin doses, although the
difference was significant at a slightly lower confidence
limit (p = 0.087; Table 7).
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Plasma Membrane GLUT4 Concentrations
GLUT4 concentrations were determined by Western blot
of immunoprecipitates from 100 pg plasma membrane total
protein from soleus muscle homogenates (Figure 10). Plasma
membrane GLUT4 concentrations did not differ between the
treatment groups (Figure 11). Although there were
significant differences in serum T3 and insulin levels due
to the treatments, muscle GLUT4 response exhibited little
change among the groups (Figure 11), which is consistent
with insulin resistance (Table 8). ■ The lack of response to
another direct regulator of GLUT4 trafficking, T3, may also
indicate T3 resistance at the peripheral target level of the
skeletal muscle in the DIO model.
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CHAPTER FOUR
DISCUSSION
This study was the first to elucidate in the diet-
induced obese (DIO), diabetic animal model the joint versus
independent roles of two key hormones responsible for
nutrient homeostasis, insulin and T3. While much of the
research in type 2 diabetes has focused intently on the
roles of insulin and intramyocellular lipids on the
regulation of skeletal muscle glucose transporter protein
GLUT4, the role of T3 on glucose homeostasis has not been
explored. It has been established that T3 directly affects
GLUT4 trafficking to the plasma membrane as well as nuclear
events leading up to an increase in GLUT4 protein synthesis
(Castello et al, 1994; Torrance et al, 1997). Fasting has
been shown to drastically reduce peripheral deiodination of
T4 to T3, but this is not taken into account during many, if
not all, of the studies done on animals or humans in the
fasted state (Byerley & Heber, 1996). The current study
has identified, in DIO rats, changes in serum
concentrations of T3 that are modified by feeding status as
well as an insulin-dependence in T3 synthesis that is
present only in the nonfasting state (Figure 7). Additional
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analyses demonstrated the impact of these hormones on
metabolic and nutrient trafficking responses. These
findings underscore the importance of performing studies
under the correct feeding status when evaluating the
metabolic defects associated with insulin resistance and
diabetes.
In order to confirm insulin resistance and impaired
glucose uptake in the DIO Wistar rats, oral glucose
tolerance testing was used to compare Wistar rats after an
11-week HF diet to SD rats that had been on the same diet
for several months. When the two strains underwent the
OGTT (Figure 6), SDs showed no sign of impaired glucose
tolerance, unlike the Wistar rats that showed marked
impairment in glucose uptake with a prolonged recovery to
baseline after 120 minutes. It is interesting to note that
these two strains reacted very differently to the same
diet, with the SDs remaining insulin-sensitive while the
Wistar rats developed Metabolic Syndrome X, and in a much
shorter time on the HF diet than the SDs. A rather
startling discrepancy in the rate of weight gain between
the two strains was also observed (Figure 4). Because
there are notable differences in both the development of
obesity and insulin resistance, usage of either strain for
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nutritional studies should be very carefully considered.
The differences in the genetic backgrounds of these two
particular strains also raise important and interesting
questions about the human population and an individual's
propensity toward becoming obese; not everyone who becomes
obese will become diabetic. Clearly, genetic factors
should be taken into account when studying obesity and the
development of the Metabolic Syndrome as well as type 2
diabetes.
Concurrent with the weight gain in Wistar rats was a
shift in the nonfasting RQ values (Figure 5) indicating
increased carbohydrate utilization and decreased lipid
oxidation that typically accompanies the development of
obesity and insulin resistance (Bray & Bouchard, 2004) .
Thus, HF feeding of Wistar rats induced a number of
physiological conditions that mimic major metabolic defects
that are observed in human obesity, insulin resistance, and
type 2 diabetes mellitus and provided a model with which to
address the impact of fasting on insulin-T3 interactions in
metabolic regulation.
The effects of fasting on whole-body metabolism were
observed in the initial phases of the study, when the RQ
values of the Wistar rats declined after a 12-hour fast
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(Figure 5). Clearly, this is not a benign effect, showing a
short-term shift from carbohydrate utilization as a fuel
source toward more lipid oxidation which occurs as a result
of glucose-sparing mechanisms that are initiated during
fasting. This itself has a significant impact not only on
metabolic substrate specificity in tissues, but also on the
animals' ability to make such a change under states of
malnourishment, such as type 2 diabetes. It supports
current research advocating calorie-restrictive diets in
order to induce weight loss and the clearance of excess
lipid depots from insulin-sensitive peripheral tissues like
the skeletal muscle, adipose depots and liver (Gazdag et
al, 2000). Fasting animals, therefore, could significantly
impact the findings from such studies and, therefore, these
results should be interpreted with caution.
One of the main goals of this study was to understand
how insulin and T3 worked to regulate nutritional
homeostasis, first by finding how insulin, in the presence.
or absence of food, regulated glucose metabolism. After
establishing insulin resistance in the DIO model, STZ
treatment eliminated endogenous insulin production and
allowed for the manipulation of serum insulin
concentrations independent of feeding and glycemic status.
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Concurrently, serum T3 concentrations (Figure 7) were
manipulated through the normal fasting inhibition of
peripheral deiodination of T4. Serum T3 was elevated in the
group that received.the full replacement dose of insulin
while being given food, which represented the control group
for this study. Interestingly, the animals that were fed
and then given replacement or low doses of insulin
experienced a drop in serum T3 levels. Insulin appears to
play a role in modulating non-fasting serum T3
concentration by regulating peripheral deiodination of T4 to
T3 in the nonfasted state. It should be noted, however,
that this insulin effect on T3 levels was observed only in
those groups that were being fed ad libitum throughout the
study. This can be explained by the inhibition of 5'MDI
that already occurs with fasting (Byerley & Heber, 1996),
which would have masked any additional effect that insulin
may have had on peripheral deiodination, as was observed in
the fed animals. However, T3 was reduced by almost 50% in
all other remaining groups that were fasted the night
before termination, including those receiving high doses of
insulin, which demonstrates the insulin-independent effect
of fasting on peripheral deiodination of T4 to T3 (Byerley &
Heber, 1996). It appears that there is an interaction
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between insulin and T3 activity. In this experiment,
fasting was shown to play an important role in the
inhibition of T3 synthesis while insulin played a secondary
role in maintaining serum T3 concentrations at normal
physiological levels under non-fasting conditions.
Serum insulin levels were also consistent with the
exogenous dosages that were given to each treatment group,
with both of the groups that received the full replacement
insulin doses exhibiting elevated levels of insulin in
comparison to the animals that received the half-dose of
insulin (Figure 8). Although the decrease in serum glucose
levels in response to high insulin dose failed to reach a
statistical significance at P<0.05 (Figure 9), it was
apparent that lower glucose levels occurred in the groups
that received the full replacement dose of insulin
(p=0.087), and the elevated levels of glucose were seen in
the groups that received the lower dose of insulin. All
subjects remained hyperglycemic in spite of the high serum
insulin levels and this is consistent with the DIO
phenotype that exhibits excessive glucose production by the
liver and impaired glucose uptake by the peripheral tissues
as a result of insulin resistance (McGarry, 2001). Thus,
the model performed according to expectations with respect
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to glucose intolerance due to attenuated insulin
responsiveness and provided the opportunity to investigate
the impact of insulin and feeding status on one of the key
glucose trafficking controls, skeletal muscle GLUT4
transporter regulation.
The entry of glucose into cells is dependent upon the
insertion of glucose transport proteins into the plasma
membrane and attenuated insulin-stimulated GLUT4
trafficking in skeletal muscle is considered a major
contributor to the development of hyperglycemia in type 2
diabetes mellitus (Boden et al, 2001; Kelley et al, 2000;
Peterson & Shulman, 2002). But despite reports
demonstrating that T3 has the ability to induce GLUT4
synthesis and trafficking in the skeletal muscle in normal,
nondiabetic animals (Castello et al, 1994; Torrance et al,
1997), these responses have not been investigated in models
of DIO and insulin resistance.
It has been clearly established that peripheral
deiodination declines significantly and thereby reduces
serum T3 when animals are fasted, as evidenced through
literature (Byerley et al, 1996; Diano et al, 1998; Wilcox
et al, 1991) as well as the results of the current study.
Whether T3 acts upon GLUT4 trafficking synergistically with
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or independently from insulin was addressed by quantifying
soleus muscle plasma membrane GLUT4 under four insulin-T3
concentration combinations. Despite treatment combinations
that exposed the soleus to high concentrations of both
insulin and T3, high concentrations of insulin with low
concentrations of T3, and low concentrations of both
hormones, there were no differences in plasma membrane
GLUT4 concentration between the control and treatment
groups. Unexpectedly, the groups that were fed ad libitum
and received half-doses of insulin did not develop the
intended high concentrations of T3 with low insulin
concentrations (Figure 7).
Since all of the subjects employed in this study were
insulin resistant DIO animals, it is not surprising that
little or no change in GLUT4 trafficking was observed in
response to different insulin concentrations (Figure 11).
However, the important finding here is that there appears
to be no fasting or feeding effect on plasma membrane GLUT4
concentrations, this despite the substantial decreases in
serum T3 concentrations that accompany fasting.
The lack of any response to feeding or fasting raises
the possibility of parallel T3 resistance in these animals.
They were unable to respond to varying doses of insulin, a
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known and potent stimulator of GLUT4 trafficking, and they
did not respond to changes in nutritional status as
reflected through serum T3, a hormone that affects GLUT4
synthesis as well as trafficking (Torrance et al, 1997).
Although the mechanism by which T3 regulates GLUT4
trafficking is not yet clearly understood, this study
suggests the potential for T3 resistance in DIO animals that
is similar to insulin resistance. A common subcellular
transduction pathway may be activated by T3 in the same
manner that insulin activates its downstream signaling
cascade, and excessive lipids could similarly be causing
blunted GLUT4 trafficking response to T3. The animals that
received the full replacement dose of insulin while feeding
ad libitum had T3 'levels that were greater that any of the
other treatment groups (Figure 7). Yet this response was
not reflected in the plasma membrane GLUT4 concentrations,
nor was it observed in the animals that received high doses
of insulin while fasting (Figure 11).
As a nuclear-acting hormone, T3 may act indirectly to
increase GLUT4 trafficking through its permissive role of
activating transcription factors that up-regulate insulin
receptor (IR) biosynthesis. The increase in the number of
IR would increase the number of ligand-receptor
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interactions, thereby stimulating more GLUT4 vesicular
translocation and docking into the plasma membrane. If the
intracellular environment is overloaded with lipids, there
is a strong possibility of compromised T3 uptake and/or
translocation into the nucleus.
Alternatively, the disconnection between feeding
status and its effect on GLUT4 trafficking may reflect the
typically slow action of the nuclear-acting T3 hormone.
Given that the animals were fed throughout the study and
only fasted overnight (16h) prior to tissue collection, the
T3-associated mechanisms may have persisted and therefore
not impacted the short-term regulation of GLUT4
trafficking. This could suggest a role for T3 in the long­
term regulation of insulin-responsiveness rather than in
short-term changes in feeding and nutritional status.
There is evidence from this study that insulin
influences deiodination of T4 to T3 in fed animals (Figure
7). Deiodination controls the amount of T3 that is present
in the blood, and T3 in turn controls the expression of
GLUT4 proteins in the myocytes (Byerley & Heber, 1996).
Therefore, it may be possible that while insulin, which
fluctuates with nutritional states over short periods of
time, acts as a short-term regulator of GLUT4 trafficking,
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T3 acts as a long-term set point in GLUT4 synthesis and
their availability within the cell.
In addition to affecting many of the same parameters
as insulin, T3 often affects them in opposite ways, for
example, by promoting catabolism and release of stored
nutrients rather than their synthesis and storage. It is
apparent that insulin and T3 may function variably as
synergists and antagonists depending upon the target tissue
and specific response. Also, like insulin, serum T3 levels
rise in response to feeding and decline in lower
nutritional states, so it is reasonable to hypothesize that
in the same manner that chronic hyperinsulinemia induces
insulin resistance, continuously elevated T3 levels may lead
to peripheral and/or central resistance to T3. One can
speculate that this could then lead to a hypothyroid
phenotype which would include decreased beta oxidation,
increased gluconeogenesis, and attenuated thermogenesis,
all of which would lead to insulin resistance, a hallmark
of Metabolic Syndrome X.
T3 has antagonizing effects on many of the same
metabolic processes as insulin, so this may also play a
large role in the dysfunctional nutrient homeostasis that
is seen in obese individuals (Wilcox et al, 1991). Even
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though T3 has been shown to play an active role in GLUT4
protein synthesis and trafficking, its importance in the
study of obesity and type 2 diabetes has been put aside for
many years. T3 affects virtually every process in nutrient
homeostasis including lipid metabolism and most
significantly, glucose homeostasis. Since fluctuations in
T3 can occur from relatively minor changes in nutritional
status, i.e. an overnight fast, a practice that is standard
in nutrition studies, T3 deserves a closer look for its
ability as a potent nuclear transcriptional activator as
well as its direct effects on peripheral tissue metabolic
processes.
This thesis represents a unique approach to studying
the in vivo regulation of glucose homeostasis in the
insulin-resistant, DIO animal model. The question of how
insulin and T3 jointly or independently regulate GLUT4
glucose transporter trafficking has been addressed for the
first time in this study and the union of these hormonal
actions into a model has been proposed for the short- and
long-term regulation of GLUT4 transporters. Further, the
profound impact on metabolic substrate selection of fasting
subjects prior to collecting and interpreting data has been
demonstrated. Studies into the nuclear transcriptional and
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protein synthetic events that follow fasting-induced T3
decline have yet to be undertaken in this obese,' diabetic
animal model and these will certainly offer an avenue of
discovery for a more comprehensive understanding of this
critical process in metabolic regulation.
Finally, unexpected differences in metabolic responses
between the two genetic strains of experimental animals,
Wistar and Sprague-Dawley, were reflective of some cases
that are currently seen with obese human populations, when
one overweight person ultimately develops type 2 diabetes.
while others do not ever develop any of its symptoms.
Therefore, the choice of animal strains in specific studies
should be carefully considered and additional studies
designed to explore the genetic and physiological
differences between these two models with the hope of
better understanding the basis for metabolic variances in
humans.
Future studies in the onset of the nuclear
transcriptional and protein synthetic events that follow T3
decline after an overnight fast has yet to be studied in
the obese, diabetic animal and is certainly an avenue that
should be further explored.
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APPENDIX A
FIGURES
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Figure 1. Insulin-Stimulated GLUT4 Trafficking. 
High serum glucose induces insulin secretion, which 
stimulates GLUT4 translocation from the cytoplasm 
to the cell membrane to enable glucose uptake from 
the blood and activation of enzymes to affect 
subsequent storage as glycogen, thereby lowering 
serum glucose levels (Diagram was reproduced with 
permission from Richard Fehn).
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Figure 2. Dysfunctional Nutrient Trafficking in Type 
2 Diabetes. Increased caloric intake and reduced 
energy expenditure leads to an accumulation of TGs in 
many tissues, especially adipose tissue, which 
causes FFA spillover to non-adipose tissue (dashed 
lines indicate major sites of dysfunctional 
trafficking). The liver, pancreas, and especially 
the skeletal muscle accumulate excess fats and 
eventually develop the insulin resistance 
characteristic of type 2 diabetes (Diagram was 
reproduced with permission from Richard Fehn).
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Figure 3. Hypothalamic Regulation of Metabolism.
The hypothalamus is the main feedback center for the 
leptin signaling pathway through the arcuate nucleus. 
A sufficient level of leptin is needed to stimulate 
the paraventricular nucleus (PVN) to secrete 
thyrotropin-releasing hormone (TRH). TRH acts on the 
pituitary to stimulate thyroid-stimulating hormone 
(TSH). TSH then acts on the thyroid to promote the 
synthesis and release of thyroid hormones T4 and T3.
T3 is the inhibitory feedback signal to the pituitary 
thyrotropes and PVN which stops TSH secretion 
(Diagram was reproduced with permission from Richard 
Fehn).
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Growth Curve: Wistar Rats
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Growth Curve: Sprague-Dawley Rats
Figure 4. Wistar and Sprague-Dawley Growth Curves. 
Growth curves while feeding on a 45% kcal by fat diet 
over a period of a) 11.7 weeks for Wistar rats and b) 
145-159 days for Sprague-Dawley rats. In spite of a 
longer period of feeding on the HF chow, the SD rats at 
145-159 days of age remained significantly smaller than 
Wistar rats at 78-97 days of age (p < 0.001). Values 
are mean+SEM, n=28-32.
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Wistar Rats’ Mean Respiratory Quotient
Figure 5. The RQ of the Wistar rats increased 
progressively with the development of obesity 
as resistance developed and lipid metabolism 
decreased. A drop in RQ value indicating 
increased lipid catabolism was observed 
following an overnight fast and STZ injection 
(84-98 Days). Values are mean+SEM, n=32.
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OGTT Following a 16-Hour Fast
Figure 6. Wistar rats showed significantly 
impaired glucose tolerance in comparison to 
nondiabetic SDs despite higher baseline 
fasting glucose levels in the SDs (p<0.05). 
Values are mean+SEM, n=28-32.
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Serum T3
Treatm ent G roups
Figure 7. Serum T3 concentrations were
maintained at nonfasting levels in fed animals 
that received the full replacement dose of 
insulin (y/hi). The serum T3 levels dropped 
significantly (p<0.01) after fasting in the 
animals that received the high doses of insulin 
(n/hi). This fasting effect was not observed 
in the group that received lower doses of 
insulin (n/lo). The fed animals receiving low 
insulin (y/lo) also had a drop in T3 (p<0.05). 
All values are mean+SEM, n=7-8.
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Serum Insulin
Treatm ent 6 roups
Figure 8. Exogenous insulin replacement with 
high doses resulted in the higher serum insulin 
levels seen in the n/hi and the y/hi groups.
The animals that received half doses, n/lo and 
y/lo showed significantly lowered serum insulin 
in comparison to the hi groups (p<0.05).
Values are mean+SEM, n=7-8.
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Serum Glucose
Figure 9. Serum glucose levels were lowered
slightly in the high insulin dose groups in
comparison to the low insulin dosages, although only 
to a statistical significance level of (p=0.087). 
This lack of response indicates insulin resistance 
in the DIO model. Values are mean+SEM, n=7-8.
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Figure 10. Representative GLUT4 Protein Bands from 
Each Treatment Group. Representative Western blot 
of GLUT4 protein bands were obtained from lOOpg of 
soleus muscle plasma membrane total protein. A MW 
ladder is represented in the first column.
Treatment groups that were fed (y) or fasted (n) 
and those receiving replacement (hi) or low (lo) 
insulin doses are shown in columns 2-5. GLUT4 
proteins migrate at a position indicating a MW of 
approximately 49.5 kDa (Arrow) (Ryder et al, 1999). 
Values are mean+SEM, n=7-8.
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Plasma Membrane GLUT4 Concentrations
Figure 11. Plasma membrane GLUT4 content was 
compared using densitometric scans of Western 
blots. None of the groups showed significant 
changes in GLUT4 concentrations in response to 
changing concentrations of insulin and T3 
indicating resistance to both hormones with 
respect to regulation of GLUT4 trafficking. 
Values are mean+SEM, n=7-8.
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PILOT STUDY DATA
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Figure 1. The control group (Vehicle:Non-fasted) was given 
saline vehicle and fed ad libitum throughout the study. 
Another group was fasted overnight (12 hours) and received 
a replacement dose of T3 in order to compensate for the 
decline in T3 that results due to decreased peripheral T4 to 
T3 deiodination during starvation states like fasting 
(T3:Faste.d) . The serum insulin levels in the T3: Fasted 
group appeared to have been restored to that of the control 
group. However, these results did not reach statistical 
significance, probably due to the small sample numbers per 
group (n = 5) which resulted in high within-group 
variability. In spite of the lack of statistically 
significant differences between the control animals 
(Vehicle:Non-Fasted) and the fasted animals given 
replacement T3 (T3: Fasted) , it did appear that T3 may be 
regulated by insulin to some degree. It was concluded that 
relying solely on fasting with exogenous T3 replacement in 
order to control insulin and T3 levels independently of each 
other would not be a sound approach. Values are in 
mean+SEM, n=5.
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Serum T3 Levels
Treatments:Feeding Status
Figure 2. The serum T3 levels paralleled the insulin 
concentrations and supported the possibility of interaction 
between insulin and T3. Values are in mean+SEM, n=5.
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APPENDIX C
TABLES
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Table 1. Treatment Protocol for Study 2.
Treatment
Groups
n Food Insulin Symbols
1 7 No Low Dose of 
Insulin
n/lo
2 8 No Replacement 
Dose of
Insulin
n/hi
3 7 Yes Low Dose of 
Insulin
y/lo
4 8 Yes Replacement 
Dose of
Insulin
y/hi
Table 2. Respiratory quotient values under 
varying substrate utilization conditions.
Substrate RQ
Carbohydrates 1.00
Proteins 0.74
Lipids 0.71
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Table 3. One-Way ANOVA - Comparing Body Weights Between 
Two Strains at Different Ages
Source of
Variation
DF SS MS F P
Between Groups 9 7874325.324 874925.036 617.330 <0.001
Residual 312 442188.956 1417.272
Total 321 8316514.280
Table 4. Two-Way ANOVA - Testing the Effects of Time and 
Strain on Glucose Tolerance
Source of
Variation
DF SS MS F P
Time 4 109669.522 27417.380 133.392 <0.001
Strain 1 23792.109 23792.109 115.754 <0.001
Time x 
Strain
4 16088.188 4022.047 19.568 <0.001
Residual 350 71938.925 205.540
Total 359 222011.900 618.418
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Table 5. Two-Way ANOVA - Testing the Effects of Feeding and 
Insulin on Serum T3 Levels
Source of
Variation
DF SS MS F P
Feeding
Status
1 2063.495 2063.495 5.699 0.025
Insulin 1 .612.142 612.142 1.691 0.205
Feeding 
Status x 
Insulin
1 1216.011 1216.011 3.358 0.078
Residual 26 9414.200 362.085
Total 29 13108.339 452.012
Table 6. Two-Way ANOVA - Testing the Effects of Feeding and 
Insulin on Serum Insulin Levels
Source of
Variation
DF SS MS F P
Fed 1 140573.461 140573.461 4.502 0.039
Insulin 1 344880.339 344880.339 11.046 0.002
Fed x Insulin 1 271.288 271.288 0.00869 0.926
Residual 4 8 " 1498668.953 31222.270
Total 51 1939817.903 38035.645
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Table 7. Two-Way ANOVA - Testing the Effects of Feeding and 
Insulin on Serum Glucose Levels
Source of
Variation
DF SS MS F P
Feeding 1 8119.737 8119.737 0.526 0.472
Insulin 1 47203.213 47203.213 3.057 0.087
Feeding x 
Insulin
1 9890.832 9890.832 0.640 0.427
Residual 49 756726.444 15443.397
Total 52 832640.707 16012.321
Table 8. Two-Way ANOVA - Testing the Effects of Feeding 
Status and Insulin on Plasma Membrane GLUT4 Concentrations
Source of
Variation
DF SS MS F P
Feeding
Status
1 0.00359 0.00359 0.575 0.454
Insulin 1 0.000132 0.000132 '0.0212 0.885
Feeding 
Status x 
Insulin
1 0.00407 0.00407 0.653 0.426
Residual 28 0.175 0.00624
Total 31 0.183 0.00589
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